Ashwin Ananthakrishnan, MD, MPH

​

Dr. Ashwin Ananthakrishnan is a Physician Investigator in the CTEU, the Director of the Crohn’s and Colitis Center at MGH, and Associate Professor at HMS. He completed his medical school training at JIPMER in India and subsequently obtained his MPH at Johns Hopkins University Bloomberg School of Public Health. After completing his Gastroenterology fellowship at the Medical College of Wisconsin, he joined the faculty at MGH where he is involved in clinical care, research, and teaching. In addition to his clinical expertise in the management of patients with complex inflammatory bowel disease (IBD), he has been involved in NIH-funded investigations using large prospective cohorts to define for the first time an important role for factors such as diet, vitamin D, stress, and sleep and determine how they may be altered to prevent disease or improve the course of established IBD. He is also conducting studies aimed to understand how an individual¹s genetics and composition of their intestinal microbiome may predispose them to developing IBD, and how they can be used to determine which treatments may be of greatest benefit in each patient. He has published over 180 manuscripts, has co-authored a textbook in IBD, and serves on multiple Editorial Boards of major GI journals.

​

​